Cellectis S.A.

Cellectis S.A.verified

ALCLS.PA

Price:

$1.668

Market Cap:

$131.05M

Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leuke...[Read more]

Industry

Biotechnology

IPO Date

2007-02-07

Stock Exchange

EURONEXT

Ticker

ALCLS.PA

The Enterprise Value as of December 2024 (TTM) for Cellectis S.A. (ALCLS.PA) is 63.48M

According to Cellectis S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 63.48M. This represents a change of -53.25% compared to the average of 135.77M of the last 4 quarters.

Cellectis S.A. (ALCLS.PA) Historical Enterprise Value (quarterly & annually)

How has ALCLS.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of Cellectis S.A. over the last ten years is 429.66M. The current 63.48M Enterprise Value has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), ALCLS.PA's Enterprise Value was at its highest in in the December 2020 quarter at 1.11B. The Enterprise Value was at its lowest in in the December 2022 quarter at 81.72M.

Quarterly (TTM)
Annual

Average

429.66M

Median

304.09M

Minimum

81.98M

Maximum

1.11B

Cellectis S.A. (ALCLS.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cellectis S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 318.39%

Maximum Annual Enterprise Value = 1.11B

Minimum Annual Increase = -73.31%

Minimum Annual Enterprise Value = 81.98M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023108.70M32.59%
202281.98M-72.24%
2021295.28M-73.31%
20201.11B156.01%
2019432.12M70.69%
2018253.16M-66.39%
2017753.27M140.73%
2016312.91M-55.25%
2015699.21M175.65%
2014253.66M318.39%

Cellectis S.A. (ALCLS.PA) Average Enterprise Value

How has ALCLS.PA Enterprise Value performed in the past?

The current Enterprise Value of Cellectis S.A. (ALCLS.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

161.99M

5-year avg

404.87M

10-year avg

429.66M

Cellectis S.A. (ALCLS.PA) Enterprise Value vs. Peers

How is ALCLS.PA’s Enterprise Value compared to its peers?

Cellectis S.A.’s Enterprise Value is less than Innate Pharma S.A. (122.80M), less than Genfit S.A. (181.92M), less than Nanobiotix S.A. (134.72M), less than Adocia SA (106.45M), greater than DBV Technologies S.A. (32.71M),

CompanyEnterprise ValueMarket cap
122.80M$157.29M
181.92M$175.76M
134.72M$151.89M
106.45M$110.39M
32.71M$67.68M

Build a custom stock screener for Cellectis S.A. (ALCLS.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectis S.A. (ALCLS.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cellectis S.A.'s Enterprise Value?

What is the highest Enterprise Value for Cellectis S.A. (ALCLS.PA)?

What is the 3-year average Enterprise Value for Cellectis S.A. (ALCLS.PA)?

What is the 5-year average Enterprise Value for Cellectis S.A. (ALCLS.PA)?

How does the current Enterprise Value for Cellectis S.A. (ALCLS.PA) compare to its historical average?